Cancer Insights

Name

Cancer Insights

Website

https://cancerinsights.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Cancer Insights is a digital cancer care platform delivering evidence-based AI at the point of care. It serves oncology specialists, patients, and caregivers, operating under the Vizlitics sub-brand to support oncology decision-making.

Ownership category

akta.pro rank

Headquarters

HQ city

Chappaqua

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Core offering

Cancer Insights is a personalized digital cancer care platform designed for patients, caregivers, and healthcare professionals. Operating through its Vizlitics sub-brand, the company delivers Evidence-Based AI at the point of care to enable data-driven decision-making in oncology settings.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Insights Platform A personalized digital cancer care platform that delivers Evidence-Based AI at the point of care to support patients, caregivers, and healthcare professionals in oncology decision-making, operated through the Vizlitics sub-brand.

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• MassChallengecoreStrategic or Co-development PartnerCancerX (an initiative with focus on cancer innovation) launched in partnership with MassChallenge. The inaugural start-up accelerator cohort consists of 16 digital health oncology companies, supporting startups over four months to scale solutions advancing cancer innovation in diagnosis, treatment, and patient care, contributing to the Cancer Moonshot's goal of reducing cancer mortality by at least 50% over 25 years.

Broad incumbents

• Tempus AI: Tempus is an AI-driven precision medicine platform that delivers oncology data, molecular profiling, and clinical decision support to oncologists and researchers — directly comparable to Cancer Insights' evidence-based AI at the point of care for oncology decisions.
• Flatiron Health: Flatiron provides oncology-specific EHR, real-world evidence, and point-of-care clinical decision support used by community oncologists and academic centers, mirroring Cancer Insights' oncology-focused evidence-based AI positioning.
• ConcertAI: ConcertAI delivers AI-powered real-world data, clinical trial matching, and decision support for oncology, closely aligned with Cancer Insights' evidence-based AI for oncologists at the point of care.
• NantHealth: NantHealth provides evidence-based clinical decision support (Eviti) and molecular profiling solutions for oncologists, comparable to Cancer Insights' evidence-based AI offering for cancer care decisions.

Direct peers

• Syapse: Syapse offers a precision-medicine platform that integrates molecular and clinical data to support oncology treatment decisions, overlapping with Cancer Insights' clinical decision support and oncology pathways positioning.
• Oncora Medical: Oncora Medical builds oncology-specific software that supports radiation and medical oncologists with workflow, documentation, and analytics tools — a directly comparable vertical oncology digital health platform.
• Cota Healthcare: Cota Healthcare combines curated real-world oncology data with decision-support tools to help oncologists select evidence-based treatments — closely matching Cancer Insights' value proposition.

Emerging players

• PicnicHealth: PicnicHealth uses AI to structure medical records and generates real-world evidence, with a strong oncology presence — overlapping with Cancer Insights' evidence-based AI approach for cancer care.
• Paige AI: Paige applies AI to oncology pathology imaging to support diagnosis and treatment decisions, sharing the evidence-based AI / oncology point-of-care positioning with Cancer Insights.
• Deep 6 AI: Deep 6 AI uses AI to mine clinical data for patient cohort identification and trial matching, including oncology workflows — adjacent to Cancer Insights' evidence-based AI for oncology decision-making.

Market position

Customer concentration

• Xx.com/cancerinsights
• LinkedInlinkedin.com/company/about

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Insights